fda glp-1 warning letters october 2025 news takes aim at telehealth companies for promoting unofficial weight loss drug dupes The New York Times spotlighted

Potential Benefits & Side Effects Observations from preclinical and limited clinical literature

The studies showing meaningful weight loss with GLP-1 medications arent about raising GLP-1 levelstheyre about activating GLP-1 receptors at a different level than your body produces naturally

References References Heffernan M, et al

Some women report improvement in symptoms such as pain, fatigue, inflammation, and endo belly, but clinical trials specifically studying semaglutide for endometriosis are still lacking

a , b , The four representative constructs used in Fig

Population pharmacokinetics of semaglutide for type 2 diabetes